References

1. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393(6685): 595-9.

2. Knopf PM, Harling-Berg CJ, Cserr HF, Basu D, Sirulnick EJ, Nolan SC et al. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J Immunol 1998; 161 (2):692—701.

3. Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit I et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest 1999; 104(9): 1199-1211.

4. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52(1): 145-176.

5. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12(2): 121-7.

6. Murphy PM. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 2002;54(2):227-9.

7. Fabbri M, Bianchi E, Fumagalli L, Pardi R. Regulation of lymphocyte traffic by adhesion molecules. Inflamm Res 1999;48(5):239^16.

8. Gordon M. Origin and Development of Neutrophils. In: Hellewell PG, Williams TJ, editors. Immunopharmacology of neutrophils . San Diego: Academic Press, 1994:27-54.

9. Rosales C, Brown EJ. Neutrophil receptors and modulation of the immune response. In: Jon S.Abramson JGW, editor. The Neutrophil. New York: IRL Press at Oxford University Press, 2001:27-52.

10. Casimir C, Teahan C. The Respiratory Burst of Neutrophils and Its Deficiency. In: Hellewell PG, Williams TJ, editors. Immunopharmacology of neutrophils. San Diego: Academic Press, 2001:55-94.

11. Borregaard N, Lollike K, Kjeldsen L, Sengelov H, Bastholm L, Nielsen MH et al. Human neutrophil granules and secretory vesicles. Eur J Haematol 1993;51(4): 187-98.

12. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89(10):3503-21.

13. Tapper H. The secretion of preformed granules by macrophages and neutrophils. J Leukoc Biol 1996;59(5):613-22.

14. Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000;52(3):349-74.

Matsuba KT, Van Eeden SF, Bicknell SG, Walker BA, Hayashi S, Hogg JC. Apoptosis in circulating PMN: increased susceptibility in L-selectin-deficient PMN. Am J Physiol 1997;272(6 Pt 2):H2852-8.

Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J 1995;9(10):866-73.

Varki A. Selectin ligands: will the real ones please stand up? J Clin Invest 1997;99(2): 158-62.

von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sei U S A 1991 ;88(17):7538-42.

Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA, Jr. et al. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991; 147(8):2565-73. Malik AB, Lo SK. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev 1996;48(2):213-29.

Ley K, Bullard DC, Arbones ML, Bosse R, Vestweber D, Tedder TF et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995; 181 (2): 669-75.

Klein CL, Bittinger F, Kohler H, Wagner M, Otto M, Hermanns I et al. Comparative studies on vascular endothelium in vitro. 3. Effects of cytokines on the expression of E-selectin, ICAM-1 and VCAM-1 by cultured human endothelial cells obtained from different passages. Pathobiology 1995;63(2):83-92.

Scholz D, Devaux B, Hirche A, Potzsch B, Kropp B, Schaper W et al. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res 1996;284(3):415-23.

Levinovitz A, Muhlhoff J, Isenmann S, Vestweber D. Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol 1993; 121 (2):449-59. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J 1994;8(12):929-38.

Buyon JP, Philips MR, Merrill JT, Slade SG, Leszczynska-Piziak J, Abramson SB. Differential phosphorylation of the beta2 integrin CD 11 b/CD 18 in the plasma and specific granule membranes of neutrophils. J Leukoc Biol 1997;61 (3):313—21. Laudanna C, Campbell JJ, Butcher EC. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science 1996;271 (5251 ):981—3.

Laudanna C, Campbell JJ, Butcher EC. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J Biol Chem 1997;272(39):24141-4.

Jones SL, Wang J, Turck CW, Brown EJ. A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. Proc Natl Acad Sei U S A 1998;95(16): 9331-6.

Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 100(11 Suppl):S25-9. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178(2):449-60.

Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR, Jones ML et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262(5139): 1580-2.

33. Lomas DA, Stone SR, Llewellyn-Jones C, Keogan MT, Wang ZM, Rubin H et al. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem 1995;270(40):23437^13.

34. Betsuyaku T, Shipley JM, Liu Z, Senior RM. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir Cell Mol Biol 1999;20(6): 1303-9.

35. Feuerhake F, Fuchsl G, Bals R, Welsch U. Expression of inducible cell adhesion molecules in the normal human lung: immunohistochemical study of their distribution in pulmonary blood vessels. Histochem Cell Biol 1998;110(4):387-94.

36. Muller WA, Randolph GJ. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 1999;66(5): 698-704.

37. Shang XZ, Issekutz AC. Beta 2 (CD 18) and beta 1 (CD29) integrin mechanisms in migration of human polymorphonuclear leucocytes and monocytes through lung fibroblast barriers: shared and distinct mechanisms. Immunology 1997;92(4):527-35.

38. Shang T, Yednock T, Issekutz AC. alpha9betal integrin is expressed on human neutrophils and contributes to neutrophil migration through human lung and synovial fibroblast barriers. J Leukoc Biol 1999;66(5):809-16.

39. Wang Q, Doerschuk CM. The signaling pathways induced by neutrophil-endothelial cell adhesion. Antioxid Redox Signal 2002;4(l):39-47.

40. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003;19(4):583-93.

41. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 1987; 139(3): 788-93.

42. Nakagawa H, Komorita N, Shibata F, Ikesue A, Konishi K, Fujioka M et al. Identification of cytokine-induced neutrophil chemoattractants (CINC), rat GRO/CINC-2 alpha and CINC-2 beta, produced by granulation tissue in culture: purification, complete amino acid sequences and characterization. Biochem J 1994;301(Pt 2):545-50.

43. Huang S, Paulauskis JD, Godleski JJ, Kobzik L. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 1992; 141 (4):981—8.

44. Ohno Y, Lee J, Fusunyan RD, MacDermott RP, Sanderson IR. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci U S A 1997;94( 19): 10279-84.

45. Barlic J, Khandaker MH, Mahon E, Andrews J, DeVries ME, Mitchell GB et al. beta-arrestins regulate interleukin-8-induced CXCR1 internalization. J Biol Chem 1999;274(23): 16287-94.

46. Aramori I, Ferguson SS, Bieniasz PD, Zhang J, Cullen B, Cullen MG. Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 1997; 16(15): 4606-16.

47. Orsini MJ, Parent JL, Mundell SJ, Benovic JL, Márchese A. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. J Biol Chem 1999;274(43):31076-86.

48. Aragay AM, Mellado M, Frade JM, Martin AM, Jimenez-Sainz MC, Martinez A et al.

Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad Sei U S A 1998;95(6):2985-90.

Barlic J, Andrews JD, Kelvin AA, Bosinger SE, DeVries ME, Xu L et al. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat Immunol 2000;l(3):227-33.

Jagels MA, Hugli TE. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. J Immunol 1992; 148(4): 1119-28. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160(5 Pt 2):S5-11. Van Furth R, Diesselhoff-den Dulk MC, Mattie H. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J Exp Med 1973;138(6): 1314-30.

Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997; 186(10): 1757-62. von Stebut E, Metz M, Milon G, Knop J, Maurer M. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1 alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha. Blood 2003; 101 (1 ):210—5. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001; 194(9): 1361-73. Izikson L, Klein RS, Luster AD, Weiner HL. Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol 2002; 103(2): 125-31.

Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000; 192(7): 1075-80.

Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 2000; 192(6): 899-905.

Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001 ;193(6):713-26.

Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med 2001 ;194(6):855-61.

Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19(l):71-82.

Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW et al. Fractalkine preferentially mediates arrest and migration of CD 16+ monocytes. J Exp Med 2003; 197( 12): 1701-7.

Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003;111(3):333^-0. Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 2001;108(9):1307-14.

Cravens PD, Lipsky PE. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol 2002;80(5):497-505.

66. Pashenkov M, Teleshova N, Kouwenhoven M, Smirnova T, Jin YP, Kostulas V et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J Neuroimmunol 2002; 122( 1 -2): 106-16.

67. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990;76(12):2421-38.

68. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136(12):4480-6.

69. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001 ;22(11):633^10.

70. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.

71. Moretta L, Biassoni R, Bottino C, Cantoni C, Pende D, Mingari MC et al. Human NK cells and their receptors. Microbes Infect 2002;4(15): 1539-44.

72. Sutherland CL, Chalupny NJ, Cosman D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol Rev 2001;181:185-92.

73. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003;3(5):413-25.

74. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002;71(2): 173-83.

75. Lang K, Drell TL, Niggemann B, Zanker KS, Entschladen F. Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett 2003;90(2-3): 165-72.

76. Kveberg L, Bryceson Y, Inngjerdingen M, Rolstad B, Maghazachi AA. Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. Eur J Immunol 2002;32(7): 1856-64.

77. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166(11):6477-82.

78. Inngjerdingen M, Damaj B, Maghazachi AA. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001 ;97(2):367-75.

79. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101 (4):746-54.

80. Maghazachi AA. G protein-coupled receptors in natural killer cells. J Leukoc Biol 2003 ;74(1): 16-24.

81. Kim CH, Pelus LM, Appelbaum E, Johanson K, Anzai N, Broxmeyer HE. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-1 l/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol 1999; 193(2):226-35.

82. Taub DD, Sayers TJ, Carter CR, Ortaldo JR. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155(8):3877-88.

83. Allavena P, Bianchi G, Zhou D, Van Damme J, Jilek P, Sozzani S et al. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol 1994;24(12):3233-36.

Giancarlo B, Silvano S, Albert Z, Mantovani A, Allavena P. Migratory response of human natural killer cells to lymphotactin. Eur J Immunol 1996;26( 12):3238—41. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995; 182(4): 104556.

Vester B, Muller K, Solbach W, Laskay T. Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun 1999;67(6):3155-9. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993;178(2):567-77.

Reiner SL, Zheng S, Wang ZE, Stowring L, Locksley RM. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med 1994; 179(2): 447-56.

Braun SE, Chen K, Foster RG, Kim CH, Hromas R, Kaplan MH et al. The CC chemokine CK beta-1 l/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. J Immunol 2000; 164(8):4025-31.

Nokihara H, Yanagawa H, Nishioka Y, Yano S, Mukaida N, Matsushima K et al. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res 2000;60(24):7002-7.

Shang X, Qiu B, Frait KA, Hu JS, Sonstein J, Curtis JL et al. Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol 2000;157(6):2055-63. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science 2001 ;294(5548): 1933-6. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999;10(4):463-71.

Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382(6592):635-8.

Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. Regulation of transendothelial migration of hematopoietic progenitor cells. Ann N Y Acad Sei 1999;872:176-85. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001 ;97(11 ):3354-60.

Jacobsen K, Kravitz J, Kincade PW, Osmond DG. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood 1996;87(l):73-82. Mohle R, Murea S, Kirsch M, Haas R. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Exp Hematol 1995;23(14):153542.

Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

100. Mohle R, Haas R, Hunstein W. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. J Hematother 1993;2(4):483-9.

101. Annunziato F, Romagnani P, Cosmi L, Lazzeri E, Romagnani S. Chemokines and lymphopoiesis in human thymus. Trends Immunol 2001 ;22(5):277-81.

102. Prockop S, Petrie HT. Cell migration and the anatomic control of thymocyte precursor differentiation. Semin Immunol 2000;12(5):435^14.

103. Norment AM, Bevan MJ. Role of chemokines in thymocyte development. Semin Immunol 2000;12(5):445-55.

104 Savino W, Mendes-da-Cruz DA, Silva JS, Dardenne M, Cotta-de-Almeida V. Intrathymic T-cell migration: a combinatorial interplay of extracellular matrix and chemokines? Trends Immunol 2002;23(6):305-13.

105. Cantor H, Weissman I. Development and function of subpopulations of thymocytes and T lymphocytes. Prog Allergy 1976;20:1-64.

106. Oosterwegel MA, Haks MC, Jeffry U, Murray R, Kruisbeek AM. Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells. Immunity 1997;6(3):351 —60.

107. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 1992; 149(7):2281—5.

108. Hernandez-Lopez C, Varas A, Sacedon R, Jimenez E, Muñoz JJ, Zapata AG et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development. Blood 2002;99(2):546-54.

109. Suzuki G, Sawa H, Kobayashi Y, Nakata Y, Nakagawa K, Uzawa A et al. Pertussis toxin-sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. J Immunol 1999;162(10):5981-5.

110. Kim CH, Pelus LM, White JR, Broxmeyer HE. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood 1998;91(12):4434^13.

111. Wilkinson B, Owen JJ, Jenkinson EJ. Factors regulating stem cell recruitment to the fetal thymus. J Immunol 1999; 162(7):3873-81.

112. Uehara S, Grinberg A, Farber JM, Love PE. A role for CCR9 in T lymphocyte development and migration. J Immunol 2002;168(6):2811-19.

113. Norment AM, Bogatzki LY, Gantner BN, Bevan MJ. Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated following pre-TCR signaling. J Immunol 2000;164(2):639-48.

114. Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P et al. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double-and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol 2000;30(1):262-71.

115. Chidgey AP, Boyd RL. Thymic stromal cells and positive selection. APMIS 2001;109(7-8):481-92.

116. Campbell JJ, Pan J, Butcher EC. Cutting edge: developmental switches in chemokine responses during T cell maturation. J Immunol 1999;163(5):2353-7.

117. Suzuki G, Nakata Y, Dan Y, Uzawa A, Nakagawa K, Saito T et al. Loss of SDF-1 receptor expression during positive selection in the thymus. Int Immunol 1998; 10(8): 1049-56.

118. Chantry D, Romagnani P, Raport CJ, Wood CL, Epp A, Romagnani S et al. Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3(+), CD4(+), CD8(low) thymocytes. Blood 1999;94(6): 1890-8.

119. Lieberam I, Forster I. The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells. Eur J Immunol 1999;29(9):2684-94.

120. Franz-Bacon K, Dairaghi DJ, Boehme SA, Sullivan SK, Schall TJ, Conlon PJ et al. Human thymocytes express CCR-3 and are activated by eotaxin. Blood 1999;93(10):3233—40.

121. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 1998;72(6):5035^t5.

122. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400(6746):776-80.

123. Tanabe S, Lu Z, Luo Y, Quackenbush EJ, Berman MA, Collins-Racie LA et al. Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. J Immunol 1997; 159(11 ):5671—9.

124. Thelen M. Dancing to the tune of chemokines. Nat Immunol 2001 ;2(2): 129-34.

125. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99( 1 ):23—33.

126. Poznansky MC, Olszak IT, Evans RH, Wang Z, Foxall RB, Olson DP et al. Thymocyte emigration is mediated by active movement away from stroma-derived factors. J Clin Invest 2002;109(8):1101-10.

127. Cyster JG. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999;189(3):447-50.

128. Muller G, Hopken UE, Stein H, Lipp M. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 2002;72(1): 1—8.

129. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002;283(l):R7-28.

130. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189(3):451-60.

131. Randolph DA, Huang G, Carruthers CJ, Bromley LE, Chaplin DD. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science 1999;286(5447): 2159-62.

132. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406(6793): 309-14.

133. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87(6): 1037-47.

134. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002; 196( 1): 65-75.

135. Nagler-Anderson C. Man the barrier! Strategic defences in the intestinal mucosa. Nat Rev Immunol 2001 ;1(1 ):59-67.

136. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Curr Opin Cell Biol 2000;12(5):563-8.

137. Eigenmann PA. T lymphocytes in food allergy: overview of an intricate network of circulating and organ-resident cells. Pediatr Allergy Immunol 2002; 13(3): 162-71.

138. Lambolez F, Azogui O, Joret AM, Garcia C, von Boehmer H, Di Santo J et al. Characterization of T cell differentiation in the murine gut. J exp Med 2002; 195(4): 437-49.

139. Miller C, Roberts SJ, Ramsburg E, Hayday AC. gamma delta cells in gut infection, immunopathology, and organogenesis. Springer Semin Immunopathol 2000;22(3):297-310.

140. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000;191(l):77-88.

141. Williams MB, Butcher EC. Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen. J Immunol 1997; 159(4): 1746-52.

142. Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated Chemotaxis. J Exp Med 1999; 190(9): 1241 — 56.

143. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000;192(5):761-8.

144. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000;165(9):5069-76.

145. Svensson M, Marsal J, Ericsson A, Carramolino L, Breden T, Marquez G et al. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J Clin Invest 2002; 110(8): 1113-21.

146. Wurbel MA, Malissen M, Guy-Grand D, Meffre E, Nussenzweig MC, Richclme M et al. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early Tand B-cell development and a reduction in T-cell receptor gammadelta(+) gut epithelial lymphocytes. Blood 2001:98(9):2626-32.

147. Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, Pan J et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 2002; 195(2) :69-275.

148. Agace WW, Roberts AI, Wu L, Greineder C, Ebert EC, Parker CM. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur J Immunol 2000;30(3):819-26.

149. Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M et al. Increased expression ofIP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999; 155(2):331 -36.

150. Mazzucchelli L, Hauser C, Zgraggen K, Wagner HE, Hess MW, Laissue JA et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol 1996; 178(2):201—6.

151. Tanaka Y, Imai T, Baba M, Ishikawa I, Uehira M, Nomiyama H et al. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol 1999;29(2):633^12.

Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000;12(5):495-503.

Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000; 191 (8): 1381—94. Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunology Today 1999;20(6):267-77.

Kunkel EJ, Ramos CL, Steeber DA, Muller W, Wagner N, Tedder TF et al. The roles of L-selectin, beta 7 integrins and P-selectin in leukocyte rolling and adhesion in high endothelial venules of Peyer's patches. J Immunol 1998; 161 (5):2449—56. Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 2003;3(3):233^12.

Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990; 136(5): 1053-68. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sei U S A 1999;96(25): 14470-5.

Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8(2): 157-65. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001 ; 194(10): 1541^-7. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal Langerhans cells. J Exp Med 1999; 190(12): 1755-68.

Drcwes LR. What is the blood-brain barrier? A molecular perspective. Cerebral vascular biology. Adv Exp Med Biol 1999;474:111-22.

Hickey WF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999;11(2): 125-37.

Drevets DA, Leenen PJ. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect 2000;2(13):1609-18.

Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991 ;28(2):254-60.

Takenaka A, Minagawa H, Kaneko K, Mori R, Itoyama Y. Adoptive transfer of experimental allergic encephalomyelitis with lectin-activated spleen cells. Part 2. Studies on T cell subsets and interleukin 2 production. J Neurol Sei 1986;72(2-3):337^15. Harling-Berg C, Knopf PM, Merriam J, Cserr HF. Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid. J Neuroimmunol 1989;25(2-3): 185-93.

Kivisakk P, Trebst C, Liu Z, Tucky BH, Sorensen TL, Rudick RA et al. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin Exp Immunol 2002; 129(3):510-8.

169. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2001; 166(12):7617-24.

170. Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA et al. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J Immunol 2004;172(l):550-9.

171. Tran EH, Kuziel WA, Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1 alpha or its CCR5 receptor. Eur J Immunol 2000;30(5):1410-5.

172. Gao YL, Rajan AJ, Raine CS, Brosnan CF. gammadelta T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis. J Autoimmun 2001 ;17(4):261—71.

173. Cardona AE, Restrepo BI, Jaramillo JM, Teale JM. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J Immunol 1999;162(2):995-1002.

174. Cardona AE, Teale JM. Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. J Immunol 2002; 169(6):3163-71.

175. Cardona AE, Gonzalez PA, Teale JM. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infect Immun 2003;71(5):2634^12.

176. Ransohoff RM. The chemokine system in ncuroinflammation: an update. J Infect Dis 2002; 186 Suppl 2:S 152-6.

Natural Immunity

Edited by L. Bertok and D.A. Chow © 2005 Elsevier B.V. All rights reserved

Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook


Post a comment